DCGI approves study on mixing of Covishield and Covaxin in India

Updated : Aug 11, 2021 07:58
|
Editorji News Desk

The Drugs Controller General of India (DCGI) has given its approval for a study on mixing of Covaxin and Covishield Covid-19 vaccines in India. This study and its clinical trials will be conducted by Christian Medical College, Vellore.

On July 29, a Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended conducting this study. In its meeting, the expert committee granted permission to CMC, Vellore for conducting the Phase-4 clinical trial covering 300 healthy volunteers, for mixing of Covid-19 vaccines Covaxin and Covishield.

The purpose of this study is to assess whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- to complete the vaccination course.

Also watch: Explained: Should you mix and match 2 different Covid-19 vaccines?

The Indian Council of Medical Research in a separate study said mixing doses of Covaxin and Covishield have shown better results in building immunity against the virus causing Covid-19.

Also watch: Mixing and matching of Covaxin and Covishield shows better results: ICMR

COVISHIELDCovid 19COVAXINDCGI

Recommended For You

editorji | India

At least nine dead, 22 injured as bus falls off road in Andhra Pradesh

editorji | India

IndiGo crisis: DGCA suspends four flight operations inspectors

editorji | India

AAP announces Kisan Mahapanchayat in Kutch to demand farmers’ rights

editorji | India

Goa nightclub fire: Luthra brothers’ deportation process from Thailand begins

editorji | India

Former Union minister Shivraj Patil passes away at 90